INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹517 Cr | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr |
What is the latest Total Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹517 Cr |
| Mar2025 | ₹376 Cr |
| Mar2024 | ₹294 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹315 Cr |
How is Total Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹517 Cr | 37.26 | |
| Mar2025 | ₹376 Cr | 28.05 | |
| Mar2024 | ₹294 Cr | 5.92 | |
| Mar2023 | ₹278 Cr | -12.02 | |
| Mar2022 | ₹315 Cr | - | |
Compare Total Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹7,432.3 Cr | 12.9% | 22.4% | 41.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 12.9% |
22.4% |
41.9% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses